Role of spinal cyclooxygenase in human postoperative and chronic pain
- PMID: 20395820
- PMCID: PMC2892621
- DOI: 10.1097/ALN.0b013e3181d94dc0
Role of spinal cyclooxygenase in human postoperative and chronic pain
Abstract
Background: Nonsteroidal antiinflammatory drugs are commonly used to treat postoperative and chronic pain. Animal studies suggest that these drugs act, in part, by blocking prostaglandin production in the spinal cord. The authors tested intrathecal ketorolac in patients with chronic or postoperative pain.
Methods: After approval of the institutional review board and the Food and Drug Administration, three clinical studies were performed. First, 15 patients receiving chronic intrathecal morphine received 0.5-2.0 mg of intrathecal ketorolac. Second, 12 patients receiving chronic intrathecal morphine received, in a double-blinded, randomized, cross-over design, intrathecal saline or 2.0 mg of ketorolac, with pain intensity as the primary outcome measure. Third, 30 patients undergoing total vaginal hysterectomy received, in a double-blinded, randomized, controlled design, intrathecal saline or 2.0 mg of ketorolac, with bupivacaine with time to first morphine dose after surgery as the primary outcome measure.
Results: Patients with chronic pain had many symptoms before intrathecal injection, without worsening of these symptoms from ketorolac. Pain intensity was reduced by intrathecal ketorolac, but this did not differ from placebo. In the first study, pain was reduced by intrathecal ketorolac in patients with high cerebrospinal fluid prostaglandin E2 concentrations but not in those with normal concentrations. Intrathecal ketorolac did not alter time to first morphine after surgery.
Conclusions: Intrathecal ketorolac did not relieve chronic pain or extend anesthesia or analgesia from intrathecal bupivacaine administered at the beginning of surgery. Under the conditions of these studies, it seems that spinal cylcooxygenase activity does not contribute to chronic or postoperative pain.
Comment in
-
Intrathecal cyclooxygenase inhibitors in humans: don't throw in the towel!Anesthesiology. 2010 May;112(5):1082-3. doi: 10.1097/ALN.0b013e3181d94e41. Anesthesiology. 2010. PMID: 20418688 No abstract available.
References
-
- The WHO three-step ladder. Geneva, Switzerland: World Health Organization; 1990. Ref Type: Report.
-
- Ramwell PW, Shaw JE, Jessup R. Spontaneous and evoked release of prostaglandins from frog spinal cord. Am J Physiol. 1966;211:998–1012. - PubMed
-
- Yaksh TL. In: Central and peripheral mechanisms for the antialgesic action of acetylsalicylic acid, Acetylsalicylic Acid: New Uses for an Old Drug. Barnet JM, Hirsh J, Mustard JF, editors. New York: Raven Press; 1982. pp. 137–52.
-
- Pellerin M, Hardy F, Abergel A. Chronic refractory pain in cancer patients: Value of the spinal injection of lysine acetylsalicylate. Presse Med. 1987;16:1465–8. - PubMed
-
- Buvanendran A, Kroin JS, Berger RA, Hallab NJ, Saha C, Negrescu C, Moric M, Caicedo MS, Tuman KJ. Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology. 2006;104:403–10. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical